Tenaya Therapeutics Inc.

11/25/2024 | Press release | Distributed by Public on 11/25/2024 07:45

Tenaya Therapeutics Doses First Patient in RIDGE™ 1 Phase 1b Clinical Trial of TN 401 for the Treatment of PKP2 Associated Arrhythmogenic Right Ventricular Cardiomyopathy